is a short contribution to World
Intelligence (2003), Issue VI, p.16, as member and nominator
2002, 2003) of the WTN (World Technology
on the topic: "Biotechnology Engineeringhumans.
might manipulation of the human genome lead and what ethical issues are
at stake? Should such bio-science now be regulated and, if so,
what means? WTN members reply to World Technology Intelligence."
other contributors are: Amory
B. Lovins (CEO, Rocky Mountain Institute, 2000 World Technology Award
Environment), and Prof. Arthur D. Caplan, University of Pennsylvania,
World Technology Award nominator, Ethics.